1. Home
  2. RBNE vs DRMA Comparison

RBNE vs DRMA Comparison

Compare RBNE & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RBNE

Robin Energy Ltd.

HOLD

Current Price

$1.91

Market Cap

4.2M

ML Signal

HOLD

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

HOLD

Current Price

$1.26

Market Cap

4.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBNE
DRMA
Founded
2024
2014
Country
Cyprus
United States
Employees
N/A
9
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RBNE
DRMA
Price
$1.91
$1.26
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
2.1M
89.4K
Earning Date
04-10-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$650.00
P/E Ratio
$42.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.67
$0.59
52 Week High
$20.57
$7.33

Technical Indicators

Market Signals
Indicator
RBNE
DRMA
Relative Strength Index (RSI) 45.12 44.86
Support Level $1.81 $1.13
Resistance Level $2.18 $1.40
Average True Range (ATR) 0.15 0.09
MACD 0.04 0.00
Stochastic Oscillator 42.95 23.64

Price Performance

Historical Comparison
RBNE
DRMA

About RBNE Robin Energy Ltd.

Robin Energy Ltd operates a tanker vessel that engages in the transportation of refined petroleum products using its Handysize product tanker.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

Share on Social Networks: